Ferric maltol

  • TRADE NAME: Accrufer (Shield Therapeutics)
  • INDICATIONS: Treatment of iron deficiency in adults.
  • SYNONYM: Accrufer
  • CLASS: Iron supplement
  • HALF-LIFE: n/a

FDA APPROVAL DATE: 07/25/2019

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Dimercaprol


An overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational diabetes and fetal malformation.

Our database has 10 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

GASTROINTESTINAL/HEPATIC
OTHER


Page last updated 11/11/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top